| human | Q5 |
| P496 | ORCID iD | 0000-0002-3502-485X |
| P1153 | Scopus author ID | 7007037653 |
| P734 | family name | Marchand | Q12795667 |
| P735 | given name | Eric | Q12788459 |
| Eric | Q12788459 | ||
| P106 | occupation | researcher | Q1650915 |
| Q37649862 | A Belgian survey on the diagnosis of asthma-COPD overlap syndrome. |
| Q64108412 | A Patient with GOLD Stage 3 COPD « cured » by One-Way Endobronchial Valves |
| Q85023960 | ABPA in adulthood: a CFTR-related disorder |
| Q46940624 | Added value of a mandible movement automated analysis in the screening of obstructive sleep apnea. |
| Q51711315 | Alterations in gene expression in hamster diaphragm after emphysema and lung volume reduction surgery. |
| Q39211039 | COPD awareness survey: do Belgian pulmonary physicians comply with the GOLD guidelines 2010? |
| Q82916810 | COPD, a systemic disease!… or not? |
| Q56997111 | Characterisation of severe obliterative bronchiolitis in rheumatoid arthritis |
| Q46113801 | Effect of pharmacotherapy on rate of decline of FEV(1) in the TORCH study. |
| Q43939965 | Granulomatous meningitis due to rheumatoid arthritis. |
| Q88309166 | How resources determine pulmonary rehabilitation programs: A survey among Belgian chest physicians |
| Q83151306 | Idiopathic chronic eosinophilic pneumonia |
| Q34624726 | Idiopathic chronic eosinophilic pneumonia. |
| Q42684166 | Idiopathic chronic eosinophilic pneumonia. A clinical and follow-up study of 62 cases. The Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P). |
| Q57299748 | Inhaled triple therapy in chronic obstructive pulmonary disease |
| Q81192105 | Is air travel safe for those with lung disease? |
| Q90722729 | Launching Global Lung Function Initiative reference values in Belgium: tips and tricks |
| Q43141522 | Long-term trials assessing pharmacological treatments in COPD: lessons and limitations |
| Q40217670 | Lung cancer in combined pulmonary fibrosis and emphysema: a series of 47 Western patients. |
| Q74316602 | Lung volume reduction surgery does not improve diaphragmatic contractile properties or atrophy in hamsters with elastase-induced emphysema |
| Q64936453 | Overuse of inhaled corticosteroids in COPD: five questions for withdrawal in daily practice. |
| Q33610551 | Physiological basis of improvement after lung volume reduction surgery for severe emphysema: where are we? |
| Q79552519 | Pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia: a series of 126 patients |
| Q80458039 | Pulmonary rehabilitation in chronic obstructive pulmonary disease |
| Q60045763 | Reassessing the BODE score as a criterion for listing COPD patients for lung transplantation |
| Q34149538 | Respiratory muscle function and drive in chronic obstructive pulmonary disease. |
| Q44380106 | Survival in COPD patients after regular use of fluticasone propionate and salmeterol. |
| Q82674674 | The BODE index as a tool to predict survival in COPD lung transplant candidates |
| Q80432768 | Withdrawal from and study design of the ISOLDE trial |
| Q84978117 | [Adherence to ambulatory oxygen therapy. Assessment and determinants in patients receiving long-term oxygen therapy] |
| Q83728206 | [Evaluation of the COPD Assessment Test in patients with stable COPD] |
| Q64044169 | [Orphan diseases: what's new since 2005?] |
| Q81336159 | [Rare and orphan diseases--a national priority] |
| Q83551896 | [Thoracic hyperinflation and COPD. Beyond respiratory mechanics and dyspnea] |
Search more.